均瑤健康(605388.SH):與江南大學簽訂戰略合作協議
格隆匯 3 月 18日丨均瑤健康(605388.SH)公佈,2021年3月18日,公司與江南大學在上海市簽訂了《戰略合作協議》。
為充分發揮雙方在各自領域的資源優勢,乙方江南大學助力甲方公司實現健康產業科技轉型,進一步推動雙方長期、全面、深入的合作,共同開拓新技術產品的全球市場,一致同意成立“均瑤健康—江南大學大健康聯合創新實驗室”(非法人機構,“聯合實驗室”)。
聯合實驗室建立以後,雙方應定期召開學術與應用研討會,研討本領域的相關科學與產業應用問題,包括但不限於益生菌、後生元、功能性乳製品和透明質酸食品等大健康食品的研發及產業化方向。
雙方一致同意,甲方每年為聯合實驗室提供300萬元,並於每年3月31日前支付給乙方,用於聯合實驗室的運行。五年合作期內提供不低於1500萬元的科研經費,用於雙方的合作。合作經費包括但不限於以下方面:
(1)圍繞大健康食品研發及產業化諮詢及論證;(2)功能菌株配方的開發及功能驗證;(3)功能菌株配方其他功能的開發;(4)功能菌株配方的技術升級與開發;(5)功能乳製品研發等。
此次《戰略合作協議》的簽訂,有利於夯實均瑤健康在功能性產品持續發力的長線邏輯,通過與在食品科技領域處於國際一流水平的江南大學長期、全面、深入的合作,充分實踐公司產品科技賦能,進一步增強公司在功能性產品領域的競爭力,提高公司產品多樣性選擇,提高市場佔有率,並獲取規模經濟效益,符合全體股東的利益和公司長遠發展戰略。
此次合作依託江南大學專業領域的資源優勢,建立聯合實驗室與人才交流培訓,有助於推動研發和創新能力,不斷推出更多健康功能性的產品,為公司的持續發展提供源動力。合作內容與公司主營業務相協調,此次合作預計不會對公司整體財務及當期經營業績構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.